Datum izmjene: 27. februara 2023. u 18:43; autor/autorica: InternetArchiveBot(razgovor | doprinosi)(Bluelink 3 books for verifiability (20230225sim)) #IABot (v2.0.9.3) (GreenC bot)
SB-204,741 je lek koji deluje kao potentan i selektivan antagonist na serotoninskom5-HT2Breceptoru, sa oko 135x selektivnošću u odnosu na blisko srodni 5-HT2C receptor, i još većom u odnosu na 5-HT2A receptor.[3] On se koristi u naučnim istraživanjima za ispitivanje funkcije 5-HT2B receptora.[4][5][6][7]
↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑Forbes, IT; Jones, GE; Murphy, OE; Holland, V; Baxter, GS (1995). „N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea: a novel, high-affinity 5-HT2B receptor antagonist”. Journal of Medical Chemistry38 (6): 855–7. DOI:10.1021/jm00006a001. PMID7699699.
↑Papageorgiou, A; Denef, C (2007). „Stimulation of growth hormone release by 5-hydroxytryptamine (5-HT) in cultured rat anterior pituitary cell aggregates: evidence for mediation by 5-HT2B, 5-HT7, 5-HT1B, and ketanserin-sensitive receptors”. Endocrinology148 (9): 4509–22. DOI:10.1210/en.2007-0034. PMID17584957.